Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

20 treatments under study, led by Maxillary Sinus Augmentation

Research Leaders

17 sponsors active, led by Hungarian Human Resources Development Operational Program (EFOP-3.6.2-16-2017-00006)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 10 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

20%

2 trials in Phase 3/4

Results Transparency

0%

0 of 9 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

10Total
Not Applicable (8)
Phase 4 (2)

Trial Status

Completed9
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 9 completed trials

Clinical Trials (10)

Research Network

Common Treatments

  • Maxillary Sinus Augmentation2
  • Osteotome Crestal Sinus Lifting1
  • Lateral Maxillary Sinus Augmentation With Allograft1
  • No Graft Material Placed Blood Clot Only1
  • Lateral Maxillary Sinus Augmentation With Xenograft1

Active Sponsors

  • Hungarian Human Resources Development Operational Program (EFOP-3.6.2-16-2017-00006)1
  • Al-Azhar University1
  • Tokat Gaziosmanpasa University1
  • Excellence Program of the Ministry for Innovation and Technology in Hungary1
  • Cairo University1

Top Investigators

Related Conditions

  • Posterior Maxillary Atrophy3

Activity Timeline